Classification of bladder cancer by microarray expression profiling: towards a general clinical use of microarrays in cancer diagnostics

Abstract excerpt

At present there are no clinically useful markers available for identifying bladder cancer patients with a high risk of disease recurrence or progression. Thus, identification and tailor-suited treatment, for example radical cystectomy and adjuvant therapy, of patients with a poor prognosis is not possible using current methods. The completion of the Human Genome Project and the simultaneous advances in...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Bladder and Urothelial Cancer Treatments
• Share to Gene expression and cancer classification
• Share to Molecular Biology Techniques and Applications